Webinar - Ramifications of Federal Panel Changes

Webinar - Ramifications of Federal Panel Changes

How will Department Of Transportation (DOT) regulated employers be impacted by the Department of Health and Human Services (HHS) newly revised Mandatory Guidelines for Federal Workplace Drug Testing Programs?

In this webinar, held April 12, 2017, Dr. Todd Simo, Chief Medical Officer at HireRight, reviews the new guidelines, explains what the changes are and discusses how these new guidelines will impact your drug screening program.

In this webinar, you'll learn about:

  • The changes HHS is putting into place
  • What these mean for federally regulated employers
  • The addition of opioid medications to federal panel
  • Utilizing oral fluid as a federal specimen in limited situations
  • How and when will DOT be impacted by these changes

Share this content

Your Information

Company Information

Copyright © 2005-2021 HireRight, LLC. All Rights Reserved   Published: Apr 12 2017